‘A wake-up call to American healthcare policy makers’: Report highlights billions in potential savings from supplements

By Stephen Daniells

- Last updated on GMT

© Pat_Hastings / Getty Images
© Pat_Hastings / Getty Images

Related tags healthcare cost savings Dietary supplements omega-3 Probiotics Lutein Zeaxanthin Amd Vitamin d Choline

Dietary supplement regimens may reduce the direct and indirect medical costs associated with specific disease-associated medical conditions, but only $59 billion are currently being captured, potentially leaving $502 billion in additional savings that could be realized, says a new report.

The “Supplements to Savings: U.S. Health Care Cost Savings from the Targeted Use of Dietary Supplements, 2022-2030”​ report by the Council for Responsible Nutrition (CRN) Foundation covers the potential healthcare costs savings associated with calcium and vitamin D, vitamin B, soluble fiber, omega-3, vitamin K2, magnesium, probiotics, lutein and zeaxanthin, and choline in the context of Coronary artery disease (CAD), osteoporosis, age-related macular degeneration (AMD), cognitive decline, irritable bowel syndrome, and childhood cognitive development disorders.

The report also details the intake levels needed to realize the additional billions in healthcare savings.

“This report is a wake-up call to American healthcare policy makers,”​ said Michael Meirovitz, director of government relations at CRN. “We must shift our public policy and healthcare spending priorities so American taxpayers can have better health—and pay less for it.”


In the U.S., 75% of health care dollars go to the treatment of chronic disease, with only 3% spent on prevention, according to the Centers for Disease Control and Prevention (CDC). In addition to healthcare spending, these chronic diseases cost the U.S. more than $260 billion annually​ in lost workforce productivity.

“When it comes to healthcare spending for chronic disease, an ounce of prevention is worth billions of pounds of cure,” ​added Meirovitz.

The report was investigated and written by research firm Frost & Sullivan. The research methodology is a cost-benefit analysis comparing disease-attributed risk and implied associated costs in dietary supplement users vs. non-users; and meta-analyses of clinical research studies for dietary supplement ingredients as they relate to reducing the risk of a given condition. Cost savings were determined by using data including target population size, risk reduction of population, and the number of possible avoided events from supplement use.

For CAD, in people 55 and over, the report identified omega-3s (1,000 mg), magnesium (400 mg), soluble fiber (25 grams), and vitamin K2 (125 or 90 micrograms), with potential cost savings of between $13 and $84 billion still to be realized.

For Osteoporosis in over 50s, the key supplements are calcium (1,000 mg) and vitamin D (15 micrograms), with potential unrealized costs savings of $155 billion.

Lutein (10 mg) and zeaxanthin (2 mg) supplements for people over 44 for AMD could yield unrealized costs savings of $943 million, said the report.

Probiotics for IBS in adults could deliver unrealized costs savings of $95 billion.

“Identifying at-risk populations early and providing targeted nutritional interventions like dietary supplements is a cost-effective approach alongside other healthy habits,”​ said Andrea Wong, Ph.D., senior vice president of scientific and regulatory affairs at CRN. “A steadily growing body of clinical research shows investing in preventive care through supplementation helps Americans avoid chronic conditions. This strategy is what we call a no-brainer.”

The complete “Supplements to Savings” economic report can be downloaded at www.SupplementsToSavings.org​.

Spreading the word…

CRN confirmed it plans to share the report and its findings with all stakeholders in the healthcare industry, including medical professionals, insurance providers, policymakers, and consumers. “It is important for as wide an audience as possible to understand both the risk reduction and cost savings achievable with use of dietary supplements,”​ said CRN.

CRN Foundation released a similar report in 2013​.

Related news

Show more

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 22-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Effera™ Human Equivalent Lactoferrin

Effera™ Human Equivalent Lactoferrin

Content provided by Helaina Inc | 17-May-2024 | Product Brochure

Helaina’s bioactive protein Effera™ is a novel branded ingredient and the first clinically studied Human Lactoferrin on the market. Human Lactoferrin is...

Pycnogenol® for women’s health

Pycnogenol® for women’s health

Content provided by Horphag Research | 15-May-2024 | White Paper

Every woman in the reproductive age is confronted with regular inconveniences connected to menstruation. For 16% to 91% of menstruating women – depending...

Related suppliers

Follow us


View more